HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Raw Materials (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Raw Materials came in at $25.1 million in Q2 2026, up 2.82% year-over-year from $24.4 million in Q2 2025, and up 11.88% quarter-over-quarter from $22.5 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Raw Materials (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Raw Materials for 12 consecutive years, with $25.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Raw Materials rose 2.82% year-over-year to $25.1 million in Q2 2026; TTM through Jun 2026 was $25.1 million, a 2.82% increase from a year earlier, with the FY2025 full-year figure at $22.5 million, down 7.79% from the prior year.
  • Raw Materials was $25.1 million for Q2 2026 at HUTCHMED (China), up from $22.5 million in the prior quarter.
  • Over five years, Raw Materials peaked at $27.4 million in Q4 2022 and troughed at $21.6 million in Q2 2022.
  • A 5-year average of $24.9 million and a median of $24.8 million in 2024 frame the typical range for Raw Materials.
  • Across the five-year window, Raw Materials jumped 163.48% in 2022 and retreated 9.09% in 2024, its largest moves.
  • Over 5 years, Raw Materials stood at $27.4 million in 2022, then fell by 2.22% to $26.8 million in 2023, then decreased by 9.09% to $24.3 million in 2024, then declined by 7.79% to $22.5 million in 2025, then advanced by 11.88% to $25.1 million in 2026.
  • The last three Raw Materials figures came in at $25.1 million (Q2 2026), $22.5 million (Q4 2025), and $24.4 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 210.98 Bn 196.99 Bn 7.24 Bn
2 Gilead Sciences 181.24 Bn 178.06 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.38 Bn 124.53 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.97 Bn 74.97 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn
6 Moderna 54.80 Bn 49.67 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.09 Bn 30.78 Bn 992.69 Mn
8 Biogen 31.34 Bn 30.05 Bn 1.96 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.12 Mn
Dec 31, 2025 22.45 Mn
Jun 30, 2025 24.43 Mn
Dec 31, 2024 24.35 Mn
Jun 30, 2024 24.79 Mn
Dec 31, 2023 26.78 Mn
Jun 30, 2023 27.23 Mn
Dec 31, 2022 27.39 Mn
Jun 30, 2022 21.61 Mn
Dec 31, 2021 15.84 Mn
Jun 30, 2021 8.20 Mn
Dec 31, 2020 4.50 Mn
Jun 30, 2020 1.37 Mn
Dec 31, 2019 2.27 Mn
Sep 30, 2019 1.77 Mn
Jun 30, 2019 1.87 Mn
Mar 31, 2019 1.33 Mn
Dec 31, 2018 652,000.00
Jun 30, 2018 639,000.00
Dec 31, 2017 314,000.00